• / Free eNewsletters & Magazine
  • / My Account
Home>FDA Clears Two Treatments for Irritable Bowel Syndrome with Diarrhea

FDA Clears Two Treatments for Irritable Bowel Syndrome with Diarrhea

3party Content

Thu, 28 May 2015

By Josh Beckerman The U.S. Food and Drug Administration has cleared two treatments for irritable bowel syndrome with diarrhea, approving drugs that are both linked to recent merger activity in the sector. Salix Pharmaceuticals Ltd.'s top-selling antibiotic Xifaxan, already approved for traveler's
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.